Get started
Author

Hans J. Hansen

Observed names: H J Hansen, HANS J. HANSEN, Hans Hansen, Hans J HANSEN, Hans J Hansen, HansJ. Hansen
Observed institutions: Tulane University, F. Hoffmann-La Roche AG, Agricultural Research Service, Amgen (United States), State University of New York, United States Department of Agriculture, NewYork–Presbyterian Hospital, SUNY Upstate Medical University, Cornell University, Montreal General Hospital, Southern Regional Research Center, United Health Services, Temple University Health System, Duke Medical Center, Immunomedics (United States), Frederick National Laboratory for Cancer Research, Center for Molecular Medicine and Immunology, National Cancer Institute, Eisai (United States), Weill Cornell Medicine, Rutgers New Jersey Medical School, Touro Infirmary, Saint Louis University, McGill University, Eisai (Japan), Columbia University, Temple University
OpenAlex ID: A5111565592
Demonstration of an Antigen Common to Several Varieties of Neoplasia
1971 · Paul Lo Gerfo, John Krupey, et al. · New England Journal of Medicine · 449
Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
2007 · Rosalyn D Blumenthal, Evelyn Leon, et al. · BMC Cancer · 277
PDF
Phase I/II Trial of Epratuzumab (Humanized Anti-CD22 Antibody) in Indolent Non-Hodgkin’s Lymphoma
2003 · John P. Leonard, Morton Coleman, et al. · Journal of Clinical Oncology · 253
CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms
2007 · Rhona Stein, M. Jules Mattes, et al. · Clinical Cancer Research · 228
Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma
2004 · John P. Leonard, Morton Coleman, et al. · Clinical Cancer Research · 226
Inhibition of Adhesion, Invasion, and Metastasis by Antibodies Targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen)
2005 · Rosalyn D. Blumenthal, Hans J. Hansen, et al. · Cancer Research · 224
PDF
Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab
2006 · Josette Carnahan, Rhona Stein, et al. · Molecular Immunology · 175
Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma
2004 · Rhona Stein, Zhengxing Qu, et al. · Clinical Cancer Research · 171
PDF
Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys
2005 · Puja Sapra, Rhona Stein, et al. · Clinical Cancer Research · 167
Antibody Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN-38) for Targeted Cancer Chemotherapy
2008 · Sung-Ju Moon, Serengulam V. Govindan, et al. · Journal of Medicinal Chemistry · 159
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody
2005 · Robert M Sharkey, Thomas M Cardillo, et al. · Nature Medicine · 148
Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies
2004 · Rhona Stein, Zhengxing Qu, et al. · Blood · 143
PDF
Biological markers in breast carcinoma.I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides
1975 · Douglass C. Tormey, T. Phillip Waalkes, et al. · Cancer · 143
Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.
2002 · Chien-Hsing Chang, Robert M Sharkey, et al. · PubMed · 129
Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody
2008 · David M. Goldenberg, Edmund A. Rossi, et al. · Blood · 127
PDF
CEACAM5-Targeted Therapy of Human Colonic and Pancreatic Cancer Xenografts with Potent Labetuzumab-SN-38 Immunoconjugates
2009 · Serengulam V. Govindan, Thomas M. Cardillo, et al. · Clinical Cancer Research · 111
PDF
Potent and specific antitumor effects of an anti-CD22–targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma
2001 · Dianne L. Newton, Hans J. Hansen, et al. · Blood · 110
Construction and characterization of a humanized, internalizing, B-cell (CD22)-specific, leukemia/lymphoma antibody, LL2
1995 · Shui-on Leung, David M. Goldenberg, et al. · Molecular Immunology · 105
A universal pretargeting system for cancer detection and therapy using bispecific antibody.
2003 · Robert M Sharkey, William J McBride, et al. · PubMed · 94
Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas
1996 · Hans J HANSEN, Gaik Lin ONG, et al. · Biochemical Journal · 87
PDF
Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma
1978 · Darrow E. Haagensen, Sven J. Kister, et al. · Cancer · 84
PDF
Carcinoembryonic Antigen Present in Human Colonic Neoplasms Serially Propagated in Hamsters
1972 · David M. Goldenberg, Hans J. Hansen · Science · 83
Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen
1993 · Hans J. Hansen, Edward S. Newman, et al. · Cancer · 82
PDF
Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate.
2003 · Gary L Griffiths, M Jules Mattes, et al. · PubMed · 79
Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22
1997 · Robert M. Sharkey, Thomas M. Behr, et al. · Cancer Immunology Immunotherapy · 79
Works count: 109
Citation count: 6,089
H-index: 46
I10-index: 84
Year
Topic
Type